Pylarify
Ended Awarded
- Contract number
- 36C24926F0045
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $674,831
Award facts
- Contract value 100% obligated
- $674,830.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., received a $674.8K delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 9 on October 1, 2025, for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection. This contract is designated as a total small business set-aside and features firm fixed-price terms with an ultimate completion date of September 30, 2026. The delivery order will be performed at the contractor's facility in North Billerica, Massachusetts.
This delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a master contract vehicle that enables the VA to efficiently procure critical radiopharmaceutical imaging agents for use across its medical centers. Lantheus Holdings, Inc., the parent company of the awardee, maintains significant indefinite delivery vehicles with the VA and Defense Health Agency, including a substantial $290M federal supply schedule contract extending through March 31, 2030. The delivery of PYLARIFY supports the VA's medical imaging programs and diagnostic capabilities for prostate cancer detection across its healthcare network.
Quick answers
Who was awarded contract 36C24926F0045?
36C24926F0045 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C24926F0045 worth?
The government has obligated $674,831 on 36C24926F0045.
Is contract 36C24926F0045 an order under another contract?
Yes. 36C24926F0045 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926F0045 competed?
The extent of competition for 36C24926F0045 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award